Abstract

HPR95 Why It Is Important to Ensure the Price Is Right: Access Restrictions for Therapies Treating Duchenne Muscular Dystrophy

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Urocortins Improve Dystrophic Skeletal Muscle Structure and Function through Both PKA- and Epac-Dependent Pathways
Julie Reutenauer-Patte ... Olivier M Dorchies
The American Journal of Pathology | VOL. 180
Julie Reutenauer-Patte, et. al.Julie Reutenauer-Patte ... Olivier M Dorchies
19 Dec 2011
Murine models of Duchenne muscular dystrophy: is there a best model?
Kristy Swiderski ... Gordon S Lynch
American journal of physiology. Cell physiology | VOL. 321
Kristy Swiderski, et. al.Kristy Swiderski ... Gordon S Lynch
14 Jul 2021
Characteristics of Patients Receiving Novel Muscular Dystrophy Drugs in Trials vs Routine Care
Dongzhe Hong ... Aaron S Kesselheim
JAMA Network Open | VOL. 7
Dongzhe Hong, et. al.Dongzhe Hong ... Aaron S Kesselheim
24 Jan 2024
Gene Editing for Duchenne Muscular Dystrophy Using the CRISPR/Cas9 Technology: The Importance of Fine-tuning the Approach.
Jacques P Tremblay ... Dominique L Ouellet
Molecular Therapy | VOL. 24
Jacques P Tremblay, et. al.Jacques P Tremblay ... Dominique L Ouellet
01 Nov 2016
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
Generating utilities for the CS-Base: a novel, generic, and patient-centered health-outcome measure
Xin Zhang ... Paul Fm Krabbe
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Xin Zhang, et. al.Xin Zhang ... Paul Fm Krabbe
06 Jul 2024
Do Behavioral Characteristics Influence the Breast Cancer Diagnosis Delay? Evidence From French Retrospective Data
Christine Le Clainche ... Jean-Christophe Vergnaud
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Christine Le Clainche, et. al.Christine Le Clainche ... Jean-Christophe Vergnaud
06 Jul 2024
Key Issues of Economic Evaluations for Health Technology Assessment in China: A Nationwide Expert Survey
Gordon G Liu ... Huajie Jin
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Gordon G Liu, et. al.Gordon G Liu ... Huajie Jin
06 Jul 2024
Valuation of Multi-Dimensional Health States With a Bolt-On: Is There a Shortcut?
Zhihao Yang ... Nan Luo
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Zhihao Yang, et. al.Zhihao Yang ... Nan Luo
06 Jul 2024
View more papers